VAG
IDXX icon

VisionPoint Advisory Group’s Idexx Laboratories IDXX Stock Holding History

VisionPoint Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed -$7.31K – 489
2024
Q2 		$7.31K Sell
15
-7
-32% -$3.51K ﹤0.01% 519
2024
Q1 		$11.9K Sell
22
-9
-29% -$4.92K ﹤0.01% 447
2023
Q4 		$17.2K Sell
31
-2
-6% -$939 0.01% 369
2023
Q3 		$14.4K Buy
33
+7
+27% +$3.49K 0.01% 414
2023
Q2 		$13.1K Buy
+26
New +$12.5K 0.01% 366
2021
Q2 		– Sell
-420
Closed -$206K – 102
2021
Q1 		$206K Sell
420
-144
-26% -$72.1K 0.1% 110
2020
Q4 		$282K Sell
564
-317
-36% -$142K 0.14% 115
2020
Q3 		$346K Sell
881
-169
-16% -$62.5K 0.15% 76
2020
Q2 		$377K Buy
1,050
+14
+1% +$4.05K 0.15% 62
2020
Q1 		$251K Buy
+1,036
New +$270K 0.12% 91

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VisionPoint Advisory Group's IDXX Position: Q3 2024 in Review

VisionPoint Advisory Group sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 15 shares — an estimated $7.31K sold.

VisionPoint Advisory Group first reported a position in IDXX in Q1 2020 and held it in 10 quarters. The position peaked at $377K in Q2 2020. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • VisionPoint Advisory Group reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • VisionPoint Advisory Group sold 15 Idexx Laboratories shares in Q3 2024, an estimated $7.31K.
  • VisionPoint Advisory Group first reported a position in Idexx Laboratories in Q1 2020 and held it in 10 quarters.
  • VisionPoint Advisory Group's Idexx Laboratories position peaked at $377K in Q2 2020.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on VisionPoint Advisory Group's 13F filing for Q3 2024, filed 15 Oct 2024.